MINI FUTURE SHORT - STRATEC BIOMEDICAL Stock

Certificat

DE000ME0EH58

Market Closed - Börse Stuttgart 12:23:45 2024-05-17 EDT
1.27 EUR +2.42% Intraday chart for MINI FUTURE SHORT - STRATEC BIOMEDICAL
1 month-25.73%
3 months+10.43%
Date Price Change
24-05-17 1.27 +2.42%
24-05-16 1.24 -1.59%
24-05-15 1.26 0.00%
24-05-14 1.26 -4.55%
24-05-13 1.32 -7.04%

Delayed Quote Börse Stuttgart

Last update May 17, 2024 at 12:23 pm

More quotes

Static data

Product typeKnock-Out with Stop Loss
Buy / SellPUT
Underlying STRATEC SE
Issuer Morgan Stanley
WKN ME0EH5
ISINDE000ME0EH58
Date issued 2023-09-07
Strike 56.12
Maturity Unlimited
Parity 10 : 1
Emission price 0.85
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 2
Lowest since issue 0.7

Company Profile

Stratec SE is a Germany-based company engaged in the development and manufacture of fully automated systems based on its own patented technologies for its partners in the fields of in-vitro diagnostics and life sciences in Germany and internationally. Its business activities are divided into three segments: Instrumentation, which designs and manufactures fully automated analyzer systems for its clinical diagnostics and biotechnology customers; Diatron, which offers systems, system components, consumables, and tests for the low throughput hematology and clinical chemistry applications, and Consumables, which develops and sells scientific materials, such as nucleic acid purification and designs and produces smart consumables in the fields of diagnostics, life sciences, and medical technology. In addition, the Company develops workflow software for networking various analyzer systems, as well as develops and sells scientific materials and technologies.
Sector
-
More about the company

Ratings for Stratec SE

Trading Rating
Investor Rating
ESG Refinitiv
B+
More Ratings

Consensus: Stratec SE

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
43.35 EUR
Average target price
42.33 EUR
Spread / Average Target
-2.35%
Consensus
-40% Exceptional extension: Our subscriptions help you unlock the best investment opportunities.
BENEFIT NOW